2 Growth Stocks Set to Flourishand 1 We Question [Yahoo! Finance]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: Yahoo! Finance
Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market's punishment can be swift and severe when trajectories fall. Luckily for you, our job at StockStory is to help you avoid short-term fads by pointing you toward high-quality businesses that can generate sustainable long-term growth. That said, here are two growth stocks with significant upside potential and one that could be down big. One Growth Stock to Sell: Novavax (NVAX) One-Year Revenue Growth: +64.7% Pioneering a nanoparticle technology that mimics the molecular structure of disease pathogens, Novavax (NASDAQ:NVAX) develops and commercializes protein-based vaccines for infectious diseases, with a primary focus on its COVID-19 vaccine and combination respiratory vaccine candidates. Why Does NVAX Give Us Pause? 6.9% annual revenue growth over the last two years was slower than its healthcare peers Estimated sales decline of 66.2% for the next 12 months implies a chall
Show less
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- New Novavax R&D Leader Raises Questions On Valuation Gap And Outlook [Yahoo! Finance]Yahoo! Finance
- 3 Companies Built Their Fortunes on COVID Vaccines, but Only 1 Has a Real Plan for What Comes Next [Yahoo! Finance]Yahoo! Finance
- Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development [Yahoo! Finance]Yahoo! Finance
- Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & DevelopmentPR Newswire
- 2 Healthcare Stocks to Target This Week and 1 That Underwhelm [Yahoo! Finance]Yahoo! Finance
NVAX
Earnings
- 2/26/26 - Beat
NVAX
Sec Filings
- 3/27/26 - Form SCHEDULE
- 3/12/26 - Form 4
- 3/9/26 - Form 4
- NVAX's page on the SEC website